27 citations
,
January 2020 in “Acta dermatovenerologica Alpina, Pannonica et Adriatica (Tiskana izd.)” Healthcare workers in Turkey experienced more skin problems due to frequent handwashing and wearing masks and gloves during the COVID-19 outbreak.
21 citations
,
February 2021 in “BMJ case reports” Anabolic steroid users may face higher risk of severe COVID-19.
17 citations
,
May 2022 in “Frontiers in Immunology” Reprogramming macrophages to resolve inflammation can help reduce severe COVID-19 complications.
16 citations
,
December 2020 in “International Journal of Clinical Practice” The pandemic changed how often certain skin conditions were diagnosed.
16 citations
,
November 2020 in “PLOS ONE” Your lifestyle and health can affect your chances of getting COVID-19; not enough sleep, lots of exercise, and hair loss can increase risk, while washing hands, eating fruit daily, and taking vitamins A and C can lower it.
9 citations
,
June 2023 in “Human Genomics” MX1 and AR genes are linked to milder COVID-19, while TMPRSS2 increases severe risk, especially in women.
7 citations
,
January 2021 in “The journal of gene medicine” Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.
5 citations
,
December 2022 in “Annals Academy of Medicine Singapore” Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.
5 citations
,
July 2021 in “medRxiv (Cold Spring Harbor Laboratory)” Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.
4 citations
,
February 2024 in “Biomedicine” Age, gender, obesity, and smoking increase the risk of severe COVID-19.
4 citations
,
May 2021 in “Journal of The American Academy of Dermatology” There's no significant genetic link between male pattern baldness and COVID-19.
4 citations
,
October 2020 in “Actas Dermo-Sifiliográficas” Common dermatology drugs were considered but are controversial for COVID-19 treatment.
3 citations
,
January 2025 in “Scientific Reports” Cepharanthine is safe but not effective in significantly reducing COVID-19 recovery time.
3 citations
,
January 2022 in “Einstein (São Paulo)” The pandemic increased stress-related skin conditions and those affected by behavior changes.
3 citations
,
March 2021 in “Journal of the European Academy of Dermatology and Venereology” The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.
2 citations
,
June 2025 in “Frontiers in Public Health” Regular mole checks and UV protection are crucial, especially for fair-skinned and health-compromised individuals.
2 citations
,
January 2024 in “European Journal of Case Reports in Internal Medicine” Beau's lines on fingernails might indicate past severe COVID-19 and risk of reinfection.
2 citations
,
December 2021 in “F1000Research” Most people in South India lack knowledge about managing COVID-19 at home.
1 citations
,
January 2023 in “bioRxiv (Cold Spring Harbor Laboratory)” Cepharanthine is safe but not clearly effective in speeding up COVID-19 recovery.
1 citations
,
November 2022 in “F1000Research” The skin conditions of Iraqi women changed during the COVID-19 pandemic, with more hair loss and skin irritation but fewer contagious skin infections.
1 citations
,
March 2022 in “Irish Journal of Medical Science” Men with androgenetic alopecia and hypertension may experience more severe COVID-19.
May 2026 in “International Journal for Educational Integrity” This study analyzes web traffic trends for 44 Spanish contract cheating websites from 2019 to 2024, focusing on the impacts of the COVID-19 pandemic and the rise of generative AI tools. It finds that organic traffic to these sites surged during the pandemic, likely due to increased remote assessments, but declined from 2023 as GenAI tools became more prevalent, potentially reducing reliance on paid services. Despite a smaller volume, paid traffic showed stronger engagement, indicating effective targeted acquisition. The study highlights that some sites still benefit from search advertising despite bans on promoting academic cheating, and it contributes to academic integrity research by using web analytics to track changes in commercial cheating behaviors.
September 2025 in “International Journal of Emergency Medicine” More skin issues appeared in the emergency department during COVID-19, highlighting the need for better dermatology training and resources.
September 2025 in “Journal of Medical Internet Research” The study assessed the impact of increased telemedicine use on health expenditures and outcomes in Japan during the COVID-19 pandemic, using a quasi-experimental design with a population of 126 million. Prefectures with higher pre-pandemic telemedicine rates saw a threefold increase in telemedicine use post-2020, leading to a 1.0% relative decrease in total health expenditure and a 1.1% decrease in inpatient expenditure, while outpatient expenditures remained unchanged. Importantly, there were no significant changes in health outcomes such as all-cause mortality and key health indicators. The findings suggest that expanding telemedicine can reduce healthcare costs without negatively affecting health outcomes.
Resident doctors had more facial skin discoloration than medical students during COVID-19.
January 2025 in “International Journal of Trichology” Severe hair loss may increase the risk of dying from COVID-19.
January 2025 in “Lume (Universidade Federal do Rio Grande do Sul)” Hair loss was the most common skin issue among healthcare workers with COVID-19.
May 2024 in “International journal of medicine and psychology.” Transcranial electrical stimulation may help reduce certain immune markers in COVID-19 patients.
Stem cell therapies, especially adipose-derived ones, show promise for treating severe COVID-19 and related conditions.
February 2024 in “PubMed” More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.